Severity
Moderate
FDA Drug recall · Reported June 20, 2018
CGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample.
Rij Pharmaceutical LLC recalled RPC APAP Elixir (Acetaminophen 160mg), Packaged in 16 FL. OZ. (473 mL) bottles, RIJ PHARM… - a moderate-severity action.
RPC APAP Elixir (Acetaminophen 160mg), Packaged in 16 FL. OZ. (473 mL) bottles, RIJ PHARM… was recalled by Rij Pharmaceutical LLC in June 20, 2018. Reason: CGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in …. Check the official notice for the remedy. Verify recall #D-0847-2018 with the FDA Drug before acting.
The recall
Rij Pharmaceutical LLC issued this moderate-severity FDA Drug recall-CGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in ….
Sourced from official FDA Drug enforcement records. Verify recall #D-0847-2018 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0847-2018) was formally reported on June 20, 2018, with the manufacturer initiating the action on May 7, 2018. It is classified under Moderate severity (Class II), with a current status of Terminated. Rij Pharmaceutical LLC is listed as the recalling firm, operating out of Middletown, NY. Federal records list the affected scope as 228 bottles.
The documented reason for this recall is: CGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample. Distribution data in the federal record shows the product reached: Nationwide in the USA. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
228 bottles
Related Recalls
6
5 from same agency
RPC APAP Elixir (Acetaminophen 160mg), Packaged in 16 FL. OZ. (473 mL) bottles, RIJ PHARMACEUTICAL CORPORATION, 40 COMMERCIAL AVENUE, MIDDLETOWN, NY, NDC 53807-129-16, UPC 353807129161
CGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | D-0847-2018 |
| Date reported | June 20, 2018 |
| Date initiated | May 7, 2018 |
| Recalling firm | Rij Pharmaceutical LLC |
| Firm location | Middletown, NY |
| Affected scope | 228 bottles |
| Distribution | Nationwide in the USA |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported June 20, 2018. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.